J. Kevin Yin, Stephanie Pepin, Robertus van Aalst, Matthew M. Loiacono, & Sandrine I. Samson. (2022). Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJ. Kevin Yin, Stephanie Pepin, Robertus van Aalst, Matthew M. Loiacono, and Sandrine I. Samson. Reply to Letter to Editor by Hadigal Et Al. Regarding the Immunogenicity and Safety Trial of High-dose Influenza Vaccine in Adults Aged ≥60 Years. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationJ. Kevin Yin, et al. Reply to Letter to Editor by Hadigal Et Al. Regarding the Immunogenicity and Safety Trial of High-dose Influenza Vaccine in Adults Aged ≥60 Years. Taylor & Francis Group, 2022.